BRPI0913839A2 - composição farmacêutica com glicosaminoglicanos e uso da mesma no tratamento de úlceras crônicas - Google Patents

composição farmacêutica com glicosaminoglicanos e uso da mesma no tratamento de úlceras crônicas

Info

Publication number
BRPI0913839A2
BRPI0913839A2 BRPI0913839A BRPI0913839A BRPI0913839A2 BR PI0913839 A2 BRPI0913839 A2 BR PI0913839A2 BR PI0913839 A BRPI0913839 A BR PI0913839A BR PI0913839 A BRPI0913839 A BR PI0913839A BR PI0913839 A2 BRPI0913839 A2 BR PI0913839A2
Authority
BR
Brazil
Prior art keywords
glycosaminoglycans
treatment
pharmaceutical composition
chronic ulcers
ulcers
Prior art date
Application number
BRPI0913839A
Other languages
English (en)
Portuguese (pt)
Inventor
Elena Cebadera Miranda
Iván López-Belmonte Encina
Maria De Los Angeles Canales Mayordomo
Original Assignee
Rovi Lab Farmaceut Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rovi Lab Farmaceut Sa filed Critical Rovi Lab Farmaceut Sa
Publication of BRPI0913839A2 publication Critical patent/BRPI0913839A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0913839A 2008-07-01 2009-06-30 composição farmacêutica com glicosaminoglicanos e uso da mesma no tratamento de úlceras crônicas BRPI0913839A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200802002A ES2340902B1 (es) 2008-07-01 2008-07-01 Composicion farmaceutica con glicosaminoglicanos y su uso en tratamiento de ulceras cronicas.
PCT/ES2009/070264 WO2010000904A1 (es) 2008-07-01 2009-06-30 Composición farmacéutica con glicosaminoglicanos y su uso en tratamiento de úlceras crónicas

Publications (1)

Publication Number Publication Date
BRPI0913839A2 true BRPI0913839A2 (pt) 2015-10-20

Family

ID=41319881

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0913839A BRPI0913839A2 (pt) 2008-07-01 2009-06-30 composição farmacêutica com glicosaminoglicanos e uso da mesma no tratamento de úlceras crônicas

Country Status (15)

Country Link
US (2) US20110201572A1 (enExample)
EP (1) EP2308497B1 (enExample)
JP (1) JP2011526608A (enExample)
CN (1) CN102176915A (enExample)
AU (1) AU2009265623B2 (enExample)
BR (1) BRPI0913839A2 (enExample)
CA (1) CA2766483C (enExample)
CY (1) CY1115780T1 (enExample)
DK (1) DK2308497T3 (enExample)
ES (2) ES2340902B1 (enExample)
MX (1) MX2010014552A (enExample)
PL (1) PL2308497T3 (enExample)
PT (1) PT2308497E (enExample)
RU (1) RU2011103459A (enExample)
WO (3) WO2010000905A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2357601B1 (es) * 2011-01-26 2012-03-21 Laboratorios Farmacéuticos Rovi, S.A. Procedimiento de preparación de derivados de glicosaminoglicanos donadores de óxido n�?trico y su uso en tratamiento de úlceras crónicas.
JP2012245943A (ja) * 2011-05-31 2012-12-13 Hitachi Automotive Systems Ltd 制御装置
JP5942133B2 (ja) * 2012-09-11 2016-06-29 学校法人関西文理総合学園 蛍光プローブ及びこれを用いた酵素活性検出方法
AU2016235662B2 (en) * 2015-03-20 2020-07-30 Aarhus Universitet Inhibitors of PCSK9 for treatment of lipoprotein metabolism disorders
EP3273239A1 (en) * 2016-07-19 2018-01-24 Laboratorios Farmacéuticos Rovi, S.A. Procedure of analysis of glycosaminoglycans, heparins and their derivatives by nuclear magnetic resonance
CN111194220B (zh) * 2017-09-05 2024-06-18 黄玲惠 用于治疗缺血的肝素组合物
CN114072430B (zh) * 2020-04-27 2023-07-28 罗威制药股份有限公司 低分子量肝素获取程序以及由此获得的低分子量肝素

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6004A (en) * 1849-01-09 chinnqck
CH636888A5 (fr) * 1977-08-08 1983-06-30 Choay Sa Heparines purifiees et leur preparation.
CA1136620A (en) * 1979-01-08 1982-11-30 Ulf P.F. Lindahl Heparin fragments having selective anticoagulation activity
FR2482611B1 (fr) * 1980-05-14 1986-03-07 Pharmindustrie Nouveaux polysaccharides sulfates, procedes pour leur preparation et leur utilisation comme medicaments
IT1245907B (it) * 1991-05-17 1994-10-25 Alfa Wassermann Spa Uso dei glicosaminoglicani nel trattamento della nefropatia diabetica e della neuropatia diabetica.
AU1173599A (en) * 1997-11-20 1999-06-15 Ikuo Yamashina Low-molecular heparin modification and remedy for skin ulcer
ES2161615B1 (es) * 1999-07-23 2003-03-16 Rovi Lab Farmaceut Sa Composiciones de heparinas de muy bajo peso molecular.
EP1357931A2 (en) 2001-01-08 2003-11-05 Human Genome Sciences, Inc. Keratinocyte growth factor-2
CU23043A1 (es) 2001-12-20 2005-05-20 Ct Ingenieria Genetica Biotech Composicion farmaceutica que contiene factor de crecimiento epidrmico (egf) para la prevencion de la amputacion de pie diabetico.
BR0309707A (pt) 2002-05-02 2005-02-09 Pfizer Prod Inc Tratamento de diabetes e complicações diabéticas com inibidores nhe-1
US20060040896A1 (en) * 2004-08-18 2006-02-23 Paringenix, Inc. Method and medicament for anticoagulation using a sulfated polysaccharide with enhanced anti-inflammatory activity
CU23388B6 (es) 2006-01-31 2009-07-16 Ct Ingenieria Genetica Biotech Composición farmacéutica de microesferas para prevenir la amputación del pie diabético

Also Published As

Publication number Publication date
WO2010000906A1 (es) 2010-01-07
CA2766483C (en) 2017-01-17
DK2308497T3 (da) 2014-07-14
CN102176915A (zh) 2011-09-07
ES2476966T3 (es) 2014-07-15
CA2766483A1 (en) 2010-01-07
JP2011526608A (ja) 2011-10-13
RU2011103459A (ru) 2012-08-10
US9211305B2 (en) 2015-12-15
EP2308497A1 (en) 2011-04-13
WO2010000905A1 (es) 2010-01-07
AU2009265623B2 (en) 2014-11-20
EP2308497B1 (en) 2014-04-16
WO2010000904A1 (es) 2010-01-07
MX2010014552A (es) 2011-04-26
ES2340902B1 (es) 2011-05-03
PL2308497T3 (pl) 2014-10-31
US20110201572A1 (en) 2011-08-18
ES2340902A1 (es) 2010-06-10
CY1115780T1 (el) 2017-01-25
AU2009265623A1 (en) 2010-01-07
US20140066402A1 (en) 2014-03-06
PT2308497E (pt) 2014-07-24

Similar Documents

Publication Publication Date Title
BRPI0918139A2 (pt) composição, alimento medicinal ou funcional, suplemento alimentar ou dietético para tratamento de distúrbios de desenvolvimento pervasivos com terapêuticos redox-ativos e uso
BR112013014189A2 (pt) composição farmacêutica que compreende transcinamaldeíco e o uso da mesma no tratamento de infecções
CL2012003026A1 (es) Composicion farmaceutica que comprende pioglitazona y linagliptina; procedimiento de preparacion; uso en el tratamiento de la diabetes tipo 2 o la obesidad.
BRPI0913822A2 (pt) forma farmacêutica oral e uso da forma farmacêutica
BRPI0817298A2 (pt) Combinações de substâncias ativas com propriedades inseticidas e acaricidas
CL2007003523A1 (es) Compuestos derivados de heterociclos sustituidos con morfolina, inhibidores de la actividad de pi3 quinasa; composicion farmaceutica que comprende a dichos compuestos; kit farmaceutico; y su uso en el tratamiento profilactico o terapeutico del cancer
CR10769A (es) Improvements in and relating to drive mechanisms suitable for use in drug delicery devices
BRPI1008045A2 (pt) derivados de aminotetralina, composições farmacêuticas contendo-os, e seu uso em terapia
BRPI0813955A2 (pt) composições terapêuticas e o uso das mesmas
SI2046324T1 (sl) Zdravljenje in preventiva mukozitisa z derivati antocianidina
BR112012031194A2 (pt) derivados de cisteamina e seu uso no tratamento de ehna
CL2008001076A1 (es) Compuestos derivados de sulfonamida; composicion farmaceutica; y uso en el tratamiento del cancer.
PT2124638T (pt) Composição de aperfeiçoamento de desempenho e utilização da mesma
BRPI1005292A2 (pt) composição de decapagem e uso da composição
BRPI1011876A2 (pt) "composição farmacêutica estável e métodos de uso da mesma"
BRPI0814769A2 (pt) Composição sinérgica compreendendo substâncias aromatizantes e ácidos orgânicos e uso da mesma
BRPI0814267A2 (pt) Agentes citotóxicos compreendendo novos derivados de tomaicmicina e o seu uso terapêutico.
BRPI0909639A2 (pt) Barra de carboidrato e uso da mesma
BRPI0719345A2 (pt) Di-hidroimidazóis substituídos e seu uso no tratamento de tumores.
BRPI0813456A2 (pt) Composto, uso do mesmo, composição farmacêutica, e, métodos para tratar um mamífero sofrendo de um distúrbio e de uma doença
BRPI0922233A2 (pt) compostos, composições farmacêiticas e métodos para uso no tratamento de síndromes metabólicas.
CL2007002207A1 (es) Compuestos derivados de sulfonilaminas; composicion farmaceutica; y uso de los compuestos en el tratamiento del glaucoma.
BRPI0913839A2 (pt) composição farmacêutica com glicosaminoglicanos e uso da mesma no tratamento de úlceras crônicas
BRPI0817974A2 (pt) Combinações de substâncias ativas com propriedades inseticidas e acaricidas.
CL2007003038A1 (es) Compuestos derivados de 2-fenil-6-aminocarbonil-pirimidina; composicion farmaceutica; y uso en el tratamiento de trastornos vasculares oclusivos.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL